Navigation Links
Dyadic International Engages The Abraham Group as Strategic Advisor
Date:6/21/2010

he advantages of Dyadic’s C1 platform technology and its R&D capabilities to major international energy groups that are committed to the efficient and rapid commercialization of cellulosic ethanol and other forms of sustainable energy."

Secretary Abraham stated, "The future of United States energy policy will be based on our country's ability to develop and implement many different types of technologies to meet our growing energy needs. We are excited to work with Dyadic whose technology has already been licensed and shown to be a key component in the process of developing and commercializing non-food biofuels and other applications worldwide."

Dyadic's President and CEO, Mark Emalfarb, added, "We are excited to have a firm of the caliber of The Abraham Group represent Dyadic. Secretary Abraham's commitment to Dyadic is a clear sign of the progress and innovations we are achieving in the area of bioenergy and lends further credibility to our company and its technologies. We expect The Abraham Group's expertise and relationships in the global energy sector will help accelerate the further development and monetization of our technologies through new licensees and other collaborations."

Dyadic believes that its proprietary and patented C1 platform technology can be used as a cost-effective method to develop and produce alternatives to oil and petroleum-based products for a variety of multi-billion dollar markets. The C1 platform technology is based on a genetically sequenced fungal microorganism that has been genomically annotated by Scripps Florida, a division of The Scripps Research Institute. As a result of more than a decade of continued research and development, the C1 platform can be readily programmed to develop and produce novel enzymes on a commercial scale at low c
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
2. Dyadic International Strengthens Management Team
3. Dyadic International Extends Collaboration With The Scripps Research Institute
4. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
5. Very Small Embryonic-Like Stem Cell Mobilization Data Presented at International Society for Stem Cell Research Annual Meeting
6. PRA International Opens Phase I Unit in Budapest
7. Hamilton Thorne to launch Staccato(TM) laser at International Society of Stem Cell Research Annual Meeting
8. PRA International Exhibits at European Hematology Association Congress
9. Prestigious International Champalimaud Vision Award to US Scientists
10. Yongye International Hosts Official NASDAQ Visit to Inner Mongolia
11. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 (PRWEB) June 18, 2013 ... and attendance system in North America, has introduced ... employee data and payroll records between ExakTime’s software ... automates ExakTime software setup and keeps employee ... employee data from a business’ current payroll software, ...
(Date:6/18/2013)... DuPont welcomes 48 of the nation’s finest ... AgriScience Teachers Ambassador Academy this week (NATAA) at the ... , The NATAA “Ag Academy” is a professional ... project of the National FFA Foundation and ... The highly recommended agriscience teachers, who are participating ...
(Date:6/18/2013)... -- regulated information — Global biopharmaceutical company UCB, Inc. and ... launch of a new Pledge campaign for people with ... empowers the millions of Americans living with ... commitment to demand more: greater understanding of the condition, ... partial-onset seizure control.  More information is available at ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2
... September 1, 2010 ... ... var shortURL ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = ...
... Deloitte Recap recently presented the Allicense 2010 ... biotechnology firm, Exelixis, in recognition of their potential ... worldwide exclusive licenses for two early-stage cancer treatments ... inhibitor programs.  In exchange, Sanofi-aventis provided Exelixis an ...
... Rx, the developers of PharmFilm® technology and a ... today announced that its partner, Reckitt Benckiser Pharmaceuticals ... plc (LSE: RB), has received approval from the ... Suboxone® (buprenorphine HCl/naloxone HCl dihydrate) sublingual film for ...
Cached Biology Technology:Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 2Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 3Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 4Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 5Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 6Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 7Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 8Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 9Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 10Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial 11Deloitte Recap Honors Sanofi-aventis and Exelixis With the Allicense 2010 Breakthrough Alliance Award for Early-Stage Collaboration in Cancer 2MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence 2MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence 3
(Date:6/17/2013)... 2013 An international team led by scientists at ... Institute and Albert Einstein College of Medicine of Yeshiva ... that attacks the tuberculosis (TB) bacterium in two different ... solve one of the major global health crises of ... strains," said Peter G. Schultz, the Scripps Family Chair ...
(Date:6/17/2013)... ST. LOUIS -- In research published in Biochemical ... describe a technology that can detect new, previously unknown ... for viruses even when doctors have not identified a ... , In the new approach, scientists use ... discover viruses. , Taking advantage of the complete deciphering ...
(Date:6/17/2013)... early onset of puberty in girls, a new clinical ... Endocrine Society,s 95th Annual Meeting in San Francisco. , ... 10 and 14. Boys undergo these changes later, usually ... is diagnosed in girls when sexual development begins before ... when these changes occur before age 9. , Recently, ...
Breaking Biology News(10 mins):New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Vitamin D supplementation may delay precocious puberty in girls 2
... to examine the role of sweeteners in the ... among various ingredients used in scientific studies, ,according ... distinctly different ingredients, such ,as pure fructose and ... and misleads ,consumers. Recent studies using ...
... Ben-Gurion University of the Negev engineers have developed ... reactors, making it unsuitable for use in nuclear arms. ... the basic synthetic element found in commercial smoke detectors ... peaceful purposes. , This technique could help "de-claw" more ...
... similar, if not lower, costs and very large reductions ... one of the key take-home messages from a series ... America,s Energy Future (RBAEF)" in a special issue of ... journal believes that the collection, which includes a comparative ...
Cached Biology News:Pure fructose frequently confused with high fructose corn syrup 2Ben-Gurion University engineers develop technique to help combat nuclear proliferation 2Cellulosic biofuel technology will generate low-cost green fuel, says major study 2Cellulosic biofuel technology will generate low-cost green fuel, says major study 3
...
GLP expression profiling service on the Affymetrix platform. Starting material can be blood, tissue or RNA. 5 day turnaround. Standard and custom post analyses of microarray data available....
... Service enables early selection of the ... providing quantitative data for sensitivity, dynamic ... antibody. Furthermore quantitative antibody fingerprints can ... of your antibodies., The full-service package ...
... kit allows for rapid, convenient, and efficient ... bind/wash/elute process utilizes a spin column to ... for concentration of proteins which were electro-eluted ... strong ion exchangers, offering high binding capacity ...
Biology Products: